BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2009954)

  • 1. Streptavidin-induced lysis of homologous biotinylated erythrocytes. Evidence against the key role of the avidin charge in complement activation via the alternative pathway.
    Muzykantov VR; Smirnov MD; Samokhin GP
    FEBS Lett; 1991 Mar; 280(1):112-4. PubMed ID: 2009954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avidin-induced lysis of biotinylated erythrocytes by homologous complement via the alternative pathway depends on avidin's ability of multipoint binding with biotinylated membrane.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Biochim Biophys Acta; 1992 Jun; 1107(1):119-25. PubMed ID: 1616915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avidin attachment to biotinylated erythrocytes induces homologous lysis via the alternative pathway of complement.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Blood; 1991 Nov; 78(10):2611-8. PubMed ID: 1824256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avidin acylation prevents the complement-dependent lysis of avidin-carrying erythrocytes.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Biochem J; 1991 Jan; 273(Pt 2)(Pt 2):393-7. PubMed ID: 1991038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target-sensitive immunoerythrocytes: interaction of biotinylated red blood cells with immobilized avidin induces their lysis by complement.
    Muzykantov VR; Zaltsman AB; Smirnov MD; Samokhin GP; Morgan BP
    Biochim Biophys Acta; 1996 Mar; 1279(2):137-43. PubMed ID: 8603079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tannin-mediated attachment of avidin to erythrocytes does not cause their lysis by complement].
    Muzykantov VR; Smirnov MD; Zal'tsman AB; Samokhin GP
    Biokhimiia; 1993 Jul; 58(7):1027-32. PubMed ID: 8364121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tannin-mediated attachment of avidin provides complement-resistant immunoerythrocytes that can be lysed in the presence of activator of complement.
    Muzykantov VR; Smirnov MD; Zaltzman AB; Samokhin GP
    Anal Biochem; 1993 Feb; 208(2):338-42. PubMed ID: 8452230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
    Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
    Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast lysis by complement and uptake by liver of avidin-carrying biotinylated erythrocytes.
    Muzykantov VR; Seregina N; Smirnov MD
    Int J Artif Organs; 1992 Oct; 15(10):622-7. PubMed ID: 1428212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avidin attachment to biotinylated amino groups of the erythrocyte membrane eliminates homologous restriction of both classical and alternative pathways of the complement.
    Muzykantov VR; Smirnov MD; Klibanov AL
    FEBS Lett; 1993 Mar; 318(2):108-12. PubMed ID: 8440366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avidin attachment to red blood cells via a phospholipid derivative of biotin provides complement-resistant immunoerythrocytes.
    Muzykantov VR; Smirnov MD; Klibanov AL
    J Immunol Methods; 1993 Feb; 158(2):183-90. PubMed ID: 8429223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.
    Zaltzman AB; Van den Berg CW; Muzykantov VR; Morgan BP
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):651-6. PubMed ID: 7537958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of avidin-carrying red blood cells with nucleated cells.
    Muzykantov VR; Zalzman AB; Fuki IV; Smirnov MD; Samokhin GP; Romanov YA
    Biochim Biophys Acta; 1993 Nov; 1179(2):148-56. PubMed ID: 8218357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
    Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
    Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotinylation of human C3.
    Berger M; Gaither TA; Cole RM; Chused TM; Hammer CH; Frank MM
    Mol Immunol; 1982 Jul; 19(7):857-64. PubMed ID: 7121468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
    Ohta H; Yoshikawa Y; Kai C; Yamanouchi K; Okada H
    Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine alternative pathway activation by unsensitized rabbit red blood cells.
    Leid RW; Coley SC; Blanchard DP; Perryman LE
    Vet Immunol Immunopathol; 1985 May; 9(1):71-85. PubMed ID: 4024451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specificity of alternative complement pathway-mediated lysis of erythrocytes: a survey of complement and target cells from 25 species.
    Ish C; Ong GL; Desai N; Mattes MJ
    Scand J Immunol; 1993 Aug; 38(2):113-22. PubMed ID: 8346410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptavidin assay by means of biotinylated actinophages.
    Fleck WF
    J Basic Microbiol; 1987; 27(10):539-42. PubMed ID: 3503924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitation of alternative pathway complement function by timed lysis assay.
    Jones BM
    J Immunol Methods; 1979; 29(3):287-92. PubMed ID: 114593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.